India's commitment to 'Ending the AIDS' epidemic

8 December 2017

The occasion of World AIDS Day was as good as any for India to launch a National Strategic Plan 2017-24, aimed at eradicating HIV/ AIDS by 2030. The country has over 2.1 million people living with HIV, the third largest number of people with HIV in the world, reports The Pharma Letter’s India correspondent.

Though there has been a 64% decline in the estimated number of annual new HIV infections in the country from 2000 to 2010, according to government data, and the trend has largely flat-lined between 2010 and 2015, a dire situation continues to persist.

"India is committed to 'Ending the AIDS' epidemic as a public health threat by 2030 in line with Sustainable Development Goals (SDG). The Indian government has reaffirmed this commitment at the United Nations General Assembly last year. However, sustained commitment and action would be needed to address the scale of challenges ahead," said an official.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK